Bontril Slow Release Interactions
There are 172 drugs known to interact with Bontril Slow Release (phendimetrazine), along with 15 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 43 are major, 127 are moderate, and 2 are minor.
- View all 172 medications that may interact with Bontril Slow Release
- View Bontril Slow Release alcohol/food interactions (3)
- View Bontril Slow Release disease interactions (15)
Most frequently checked interactions
View interaction reports for Bontril Slow Release (phendimetrazine) and the medicines listed below.
- Abilify (aripiprazole)
- Adipex-P (phentermine)
- atenolol
- Benadryl (diphenhydramine)
- celecoxib
- cetirizine
- Contrave (bupropion / naltrexone)
- Cymbalta (duloxetine)
- doxycycline
- Effexor (venlafaxine)
- Effexor XR (venlafaxine)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flexeril (cyclobenzaprine)
- Flonase (fluticasone nasal)
- gabapentin
- Lexapro (escitalopram)
- meloxicam
- metformin
- omeprazole
- phentermine
- Provigil (modafinil)
- Prozac (fluoxetine)
- simvastatin
- Singulair (montelukast)
- Synthroid (levothyroxine)
- Topamax (topiramate)
- trazodone
- Vitamin D3 (cholecalciferol)
- Xanax (alprazolam)
- Zyrtec (cetirizine)
Bontril Slow Release alcohol/food interactions
There are 3 alcohol/food interactions with Bontril Slow Release (phendimetrazine).
Bontril Slow Release disease interactions
There are 15 disease interactions with Bontril Slow Release (phendimetrazine) which include:
- cardiovascular
- glaucoma
- agitation
- cardiac disease
- glaucoma
- hypertension
- psychiatric disorders
- pulmonary hypertension
- substance abuse
- tics
- diabetes
- liver disease
- renal dysfunction
- seizure disorders
- diabetics
More about Bontril Slow Release (phendimetrazine)
- Bontril Slow Release consumer information
- Compare alternatives
- Reviews (38)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: anorexiants
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.